Vital Farms, Inc. (VITL) - Q2 2025 Filing Summary
Business Context and Reporting Period
This summary covers Vital Farms, Inc.'s Form 10-Q for the quarterly period ended June 29, 2025. Vital Farms is a leading U.S. brand of pasture-raised eggs and butter, operating as a public benefit corporation. The company sources products from a network of over 500 family farms and sells primarily through retail and foodservice channels. The fiscal year consists of 52 weeks, with the quarter representing a 13-week period.
Key Financial Metrics
| Metric | Q2 2025 (13-Weeks) | Q2 2024 (13-Weeks) | YTD 2025 (26-Weeks) | YTD 2024 (26-Weeks) |
|---|---|---|---|---|
| Net Revenue | $184.8 million | $147.4 million | $347.0 million | $295.3 million |
| Gross Profit | $71.8 million | $57.7 million | $134.3 million | $116.6 million |
| Gross Margin | 39% | 39% | 39% | 39% |
| Net Income | $16.6 million | $16.3 million | $33.5 million | $35.4 million |
| Diluted EPS | $0.36 | $0.36 | $0.73 | $0.79 |
| Operating Cash Flow (YTD) | $4.5 million (vs. $40.1 million YTD 2024) | |||
| Cash & Equivalents | $108.2 million (as of June 29, 2025) | |||
| Debt | $0 outstanding on $60M JPMorgan Credit Facility |
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 25% quarter-over-quarter (QoQ) and 17% year-to-date (YTD), driven by a combination of price/mix benefits and volume increases. Retail channel revenue grew significantly.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses rose 17% QoQ due to increased marketing spend, higher employee headcount, and technology costs. Shipping and distribution costs increased 25% QoQ, tracking with higher sales volume.
- Cash Flow Deterioration: Net cash provided by operating activities dropped significantly to $4.5 million YTD 2025 compared to $40.1 million YTD 2024. This was primarily driven by a $40.3 million net cash outflow from changes in operating assets and liabilities (increased inventory and receivables) and a decrease in net income.
- Investing Activities: Net cash used in investing activities was $45.9 million YTD 2025, largely due to $45.1 million in purchases of available-for-sale securities and $10.0 million in property, plant, and equipment (PP&E).
- Inventory Build: Total inventories increased from $23.7 million at year-end 2024 to $42.7 million in Q2 2025, reflecting strategic stockpiling and growth in butter and egg-related products.
Guidance, Outlook, and Risks
- Capital Expenditures: Management anticipates significant capital outlays in the next 12 months, including $90M–$110M for a new egg washing and packing facility in Seymour, Indiana; $10M–$14M for a new grading system in Missouri; and $15M–$25M for "accelerator farms."
- Internal Control Weakness: The company disclosed a material weakness in internal control over financial reporting related to the revenue process (sales order entry and invoicing). Remediation is ongoing and expected to conclude by the end of fiscal 2025. Disclosure controls were deemed ineffective as of June 29, 2025.
- Agricultural Disease Risks: The company continues to monitor Highly Pathogenic Avian Influenza (HPAI) and Egg Drop Syndrome (EDS). Eight farms experienced EDS outbreaks in fiscal 2025. While supply has not been materially disrupted, widespread outbreaks remain a risk.
- Tariffs and Inflation: The company notes potential impacts from recently announced U.S. tariffs (effective August 2025) on imported butter, packaging, and processing equipment. Inflationary pressures on feed costs and labor remain a concern.
- Customer Concentration: One customer (Customer A, identified as UNFI/Whole Foods in risk factors) accounted for approximately 21% of Q2 2025 revenue.
Investor Verification Checklist
- Remediation Timeline: Verify the progress of the remediation plan for the material weakness in internal controls over financial reporting, specifically regarding revenue recognition processes.
- Working Capital Trends: Monitor the trajectory of accounts receivable and inventory levels to ensure the sharp decline in operating cash flow is not indicative of a structural liquidity issue.
- Capital Expenditure Execution: Track the actual spend against the projected $115M–$149M range for new facilities and equipment to assess impact on future free cash flow.
- Disease Outbreak Impact: Watch for updates on EDS and HPAI outbreaks within the farm network and any resulting supply constraints or culling costs.
- Tariff Exposure: Assess the specific impact of new U.S. tariffs on the cost of imported butter and packaging materials, given the company's reliance on these inputs.